ERBB2 and triple-negative breast carcinoma: The clinicopathological subtypes for breast cancer are classified as luminal A, luminal B, HER2+/HR+, HER2+/HR−, and triple-negative breast cancer (TNBC) in the Chinese society of clinical oncology (CSCO) guidelines.